Letrozole is a potent non-steroidal aromatase inhibitor primarily used in the clinical treatment of hormone-dependent breast cancer in postmenopausal women. By effectively blocking the enzyme responsible… Read more



















Letrozole is a potent non-steroidal aromatase inhibitor primarily used in the clinical treatment of hormone-dependent breast cancer in postmenopausal women. By effectively blocking the enzyme responsible for estrogen synthesis, it helps prevent cancer recurrence and manages tumor progression. Because precise measurement is vital in pharmaceutical manufacturing, laboratories rely on a comprehensive range of reference standards, including the active pharmaceutical ingredient, its pharmacopeial and non-pharmacopeial impurities, and specific metabolites such as the carbinol derivative. These high-quality compounds are essential for rigorous impurity profiling and method validation, ensuring compliance with strict regulatory guidelines. Furthermore, stable isotope labelled compounds—such as deuterated variants—are crucial for accurate quantification in bioanalytical assays and complex quality control procedures. Accessing these well-characterized materials supports reliable analytical method development and consistent performance monitoring throughout the entire drug development and manufacturing lifecycle.